BioSpace News Archive

KinoPharma, Inc., and the National Institutes for Quantum and Radiological Science and Technology are pleased to announce that they have entered a contract for collaborative research on efficacy evaluation of the compound KPO1143, developed by KinoPharma

Funding to advance a breakthrough non-hormonal treatment for symptoms of the menopause, into a Phase 2b study in Q4 2018

Promethera Biosciences SA today announced that Health Canada has confirmed a cGMP compliance status for the company’s production facility in Durham, North Carolina.

ACER’S NEW WINDOWS MIXED REALITY HEADSET IS OPTIMIZED FOR VIRZOOM’S REVOLUTIONARY VZFIT VR FITNESS SYSTEM

Luye Pharma Group released its financial results for the first half of 2018 on August 26, with the financial report showing the company has maintained strong business performance and double-digit growth in the sale of its established products - significantly higher than the industry average.

Soligenix, Inc. announced today that Dr. Oreola Donini, Chief Scientific Officer, will be presenting preclinical and clinical data illustrating the potential utility of the Innate Defense Regulator technology in the treatment of infectious disease in a poster session at the upcoming European Society of Clinical Microbiology and Infectious Diseases / American Society of Microbiology Conference

Concord Medical Services Holdings Limited today announced its unaudited consolidated financial results for the six months ended June 30, 2018[1].

TapImmune Inc. will participate at two upcoming industry conferences.

Presentation to Highlight the Challenges of Viral Targets in Cancer

The 3D TORONTO Sign, Calgary Tower, CN Tower, Kipnes Lantern/National Arts Centre, New York Stock Exchange, Niagara Falls, and Peace Bridge Among Famous Canada and U.S. Locations to Light Up in the Colors of Stand Up To Cancer